AI-generated · cited to primary sources · not investment advice
The acquisition was completed within the guided quarter. Management stated that Imperial Blue was acquired on 30 November 2025, with December 2025 included in Q3 FY26 financials. (1 met across 1 tracked commitment)
“Brands under House of TI to be launched across 10+ markets in FY27, on the back of Imperial Blue distribution network”
The Q3 FY26 launch commitment was achieved on schedule. (2 met across 2 tracked commitments)
“Seven Islands Pure Malt Whisky: Launched in Nov-25; Planned expansion into all key luxury markets across India in FY27”
Realise lower Scotch import costs following the India-UK Free Trade Agreement. — target: Customs duty reduction from 150% to 75% for Scotch imports (+1 more commitment)
“The India-UK Free Trade Agreement came into effect in mid-July and the reduced Scotch import costs are expected to show up in our financials from Q3 FY27.”
Deliver double-digit volume growth for the Imperial Blue brand in FY27. — target: Double-digit volume growth (+4 more commitments)
“IB crossed 2 million cases in both May and June, reinforcing our confidence in delivering double-digit volume growth for the brand in FY27.”
Launch new products to fill portfolio gaps and support mid-double-digit volume growth. — target: New launches over the next 12 to 36 months; mid-teens CAGR through FY29 (+4 more commitments)
“Going forward, of course, there are a few vacant spaces in our portfolio, and we would be looking at new launches in the next 12 to 36 months to complete our portfolio. And with the new launches in place, we expect the volume growth to be in mid-double digit. We will have a CAGR of mid-teens till FY29.”
See the full cited Management analysis of Tilaknagar Inds.
The broader existing-brand portfolio is expanding in reach and category coverage. Tilaknagar reported strong performance from its existing portfolio, while Mansion House Whisky expanded into several additional markets and new premium and luxury launches were added. However, the document does not provide a separate revenue share or volume number for this group. (5 expanding)
“>90% IB volumes under TI operations ... 1 State Remains under TSMA (max Q4 FY27 exit) ... 40+ Units Post TSMA exit for steady state business”
Brand strength continued to be a major advantage and broadened beyond the earlier Mansion House and Imperial Blue combination. Mansion House remained India's largest-selling brandy and the world's second-largest brandy by volume, while Courrier Napoleon was reported as the third-fastest-growing brandy globally. The company also won multiple awards for Mansion House Whisky, Mansion House Brandy and Courrier Napoleon products, supporting continued brand recognition. (2 expanding, 1 contracting, 2 shifted across 3 engines)
“IB 5.4 NA 17.7% ... Acquisition of Imperial Blue was completed in Nov-25, hence, the YoY growth is not applicable Q1 FY27”
The geographic model was shifting from a South India concentration toward a broader national footprint. South India still accounted for 86% of volumes in FY25, unchanged from FY20-FY24, so the existing base remained concentrated. However, the company added Mansion House Whisky in Odisha, Telangana and Kerala, launched Monarch Legacy Edition in Odisha, Kerala and Karnataka, and began distributing craft brands in Odisha, Puducherry and export markets. The planned Imperial Blue acquisition was expected to materially accelerate the pan-India shift. (5 shifted)
“The change has been made post acquisition of Imperial Blue as the business has expanded into multiple non-corporation market states ... management has taken the view to update the presentation / disclosure in line with future prospects and better comparability with peers”
The cost advantage remains under development rather than fully realized. Packaging inflation, particularly higher glass costs, reduced adjusted gross margin to 42.1% from 45.2% in Q4 FY26, a decline of 3.1 percentage points. Management expects supply-chain optimization and integration benefits to expand consolidated margins by approximately 250 basis points, but current-quarter cost pressure was negative. (1 contracting)
“Adjusted for subsidy, we have achieved a gross profit of Rs. 432 crore in Q1 FY27 and a margin of 42.1% compared to 45.2% in Q4 FY26.”
See the full cited Business Model analysis of Tilaknagar Inds.
The latest available data confirms a sharp step-up in scale: ex-Imperial Blue volumes grew 16.8% year on year in Q3 FY26 and 19.5% over nine months, while Imperial Blue added 17.9 lakh cases in December. The combined business reached 53.1 lakh cases in Q3, up 76.1% year on year. This indicates strong current momentum, but the comparison is distorted by the acquisition and does not provide several sequential quarters. (5 accelerating across 5 signals)
“IB 5.4 NA5 17.7%. Encouragingly, IB crossed 2 million cases in both May and June, reinforcing our confidence in delivering double-digit volume growth for the brand in FY27.”
Tilaknagar has begun expanding its luxury portfolio through Seven Islands Pure Malt Whisky, launched in Maharashtra, Puducherry and selected export markets. The company also plans to use Imperial Blue's wider distribution network to launch more whisky brands and Spaceman products in additional markets. This is a newly disclosed expansion initiative with no earlier quarterly rollout data in the document. (1 new trend across 1 signal, 1 leading indicator)
“Brands under House of TI to be launched across 10+ markets in FY27, on the back of Imperial Blue distribution network.”
Imperial Blue volume data is not reported because the acquisition was still pending during Q2 FY26. The Competition Commission approved the transaction on 7 October 2025, and management expected completion in Q3 FY26. This is a newly emerging growth opportunity, but no cases or quarter-on-quarter volume trend is yet available. (5 new trend across 5 signals, 1 leading indicator)
“Largest P&A player in South India with ~40% market share (ex-Tamil Nadu).”
Manufacturing capacity has expanded materially alongside the Imperial Blue acquisition: the number of units increased from 21 in FY25 to more than 40 in FY26. In Andhra Pradesh, Prag Distillery capacity increased six-fold from 6 lakh to 36 lakh cases per year, covering about 50% of TI's AP requirements. The expansion is active and accelerating, with further manufacturing-footprint optimisation planned for the next few years. (1 accelerating, 4 new trend across 5 signals, 1 leading indicator)
“Planned Expansion in Manufacturing Footprint to Ensure Supply-side Safety.”
Bartisans is being used to build a newer route to market and product pipeline. Tilaknagar increased its stake to 41.5%, and the funds will support quick-commerce expansion, packaging innovation and joint launches. — Bartisans strategic investment: +5.3 percentage points in ownership
“During the quarter, we also doubled down on our investment in Bartisans by increasing our stake from 36.2% to 41.5%. The proceeds from this investment will be used to expand within the quick commerce segment, product and packaging innovation and for collaborative launches with TI.”
See the full cited Future Growth analysis of Tilaknagar Inds.
The risk is INTENSIFYING and remains HIGH. Gross margin fell by 305 basis points from 45.2% in Q4 FY26 to 42.1% in Q1 FY27. Management specifically attributes the decline to inflationary pressure, particularly in glass and other packaging inputs. Although ENA prices softened and partly offset the pressure, the latest quarter shows a clear deterioration in profitability. (1 intensifying, 1 high-severity)
“Fall of 305 bps vs 45.2% margin in Q4 FY26; fall on account of inflationary pressures. Excluding impact of inflationary pressure, the EBITDA margin would be ~17%”
Inventory days increased from approximately 15 days in Q2 FY25 to 18.5 days in September 2025. Management deliberately built inventory ahead of expected demand in Andhra Pradesh, Karnataka and other markets. This is a measurable increase in funds tied up in inventory and therefore a worsening working-capital risk, although it was demand-led rather than caused by reported collection problems. (5 intensifying, 5 high-severity)
“Total Gross Debt 2,241; Cash & Cash Equivalents 141; Total Net Debt 2,100. Post-moratorium, the loan has a balloon repayment structure, with 65% of the principal repayment to be made in the 6th year. The effective interest rate on the above term loan is ~10%-11%”
Execution risk is becoming more immediate because the Prag distillery expansion is under way and must be commissioned within the disclosed 12-month period. Capacity is planned to rise six-fold, from about 6 lakh to 36 lakh cases annually, with Rs. 34 crore already paid against a total stated capex of about Rs. 59 crore and equipment orders placed. The project is strategically important for Andhra Pradesh and the incoming Imperial Blue business, so delays could disrupt supply or increase costs. Severity remains high. (3 intensifying, 1 emerging, 1 easing, 1 high-severity)
“40+ Units Post TSMA exit for steady state business; Bottling Charges: Entering new arrangement with bottlers”
The risk remains materially high. Management reported that Maharashtra-made liquor (MML) caused the prestige category in Maharashtra to decline by about 25%, while MML volumes were estimated at 500,000-600,000 cases per month and management could not determine whether this was the peak. The issue is also under legal challenge. This is fresh evidence of regulatory and competitive disruption in a key state market. (1 intensifying, 2 easing, 2 stable, 1 high-severity)
“Apr-26 was impacted by a combination of TSMA exit-related disruptions across Odisha, Punjab, Uttarakhand and Karnataka, as well as state elections in key markets such as Assam and West Bengal.”
Volume growth was strong at 16.2% year on year, while revenue adjusted for subsidy grew only 9.3%. Net sales realization improved 1.8% sequentially to Rs. 1,215 per case, and management expects realization to increase going forward. The gap between volume and revenue growth remains a concern, but the sequential realization improvement suggests the risk is easing from the prior quarter. (1 easing, 1 stable, 1 high-severity)
“Volumes 8.7 mn cases... IB 5.4... Ex-IB 3.3”
See the full cited Risk analysis of Tilaknagar Inds.
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.